Analyze Diet
Journal of veterinary internal medicine2020; 34(2); 1013-1017; doi: 10.1111/jvim.15697

Long-term hormone replacement treatment in a horse with central diabetes insipidus.

Abstract: This case report describes the clinical presentation, and the diagnostic and therapeutic approaches of a 4-year-old gelding presented with severe polyuria and polydipsia. The horse was diagnosed with central diabetes insipidus. After diagnosis, different therapeutic regimens with intraocular desmopressin acetate (Minirin, Ferring GmbH, Kiel, Germany) (a synthetic arginine vasopressin analog) were tested, but without success. Only the subcutaneous injection of desmopressin acetate (Minirin, Ferring GmbH) led to an increase in urine specific gravity and a decrease in water intake and urine output. Daily subcutaneous treatment with desmopressin acetate (Minirin, Ferring GmbH) was initiated and maintained for at least 5 years. The horse did not develop adverse effects or re-occurrence of the initial complaints. This case report describes successful long-term treatment of central diabetes insipidus in a horse.
Publication Date: 2020-01-21 PubMed ID: 31960998PubMed Central: PMC7096602DOI: 10.1111/jvim.15697Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper presents a unique case report describing the successful long-term hormone replacement therapy administered to a horse diagnosed with central diabetes insipidus.

Research Background and Objective

  • This research paper revolves around the case study of a 4-year old gelding diagnosed with central diabetes insipidus.
  • The researchers aimed to explore and identify a successful long-term therapy to treat this rather uncommon condition in horses.

Diagnosis Methods

  • The gelding initially presented with severe polyuria and polydipsia, leading veterinarians to suspect an issue with the horse’s water metabolism.
  • Further diagnostic evaluation confirmed the horse was suffering from central diabetes insipidus, a condition distinguished by the inability of the kidneys to conserve water due to a lack of antidiuretic hormone (ADH) vasopressin.

Treatment Strategy

  • The researchers initially tried different therapeutic regimens involving intraocular desmopressin acetate, a synthetic form of vasopressin the body naturally produces to regulate water. However, these treatments did not yield satisfactory results.
  • The treatment approach shifted towards subcutaneous injection of desmopressin acetate, which led to promising changes. There was an increase in the urine’s specific gravity and a notable decrease in water intake and urine output—indicators of improved water metabolism within the horse’s body.
  • Seeing the positive effects, a daily subcutaneous injection procedure was initiated and continued for at least five years.

Results of the Long-term Treatment

  • The horse didn’t show an occurrence of the initial symptoms and did not exhibit any notable adverse effects from the hormone replacement treatment.
  • The case study, therefore, presented a successful long-term treatment strategy for central diabetes insipidus in a horse using hormone replacement therapy, specifically through subcutaneous injections of desmopressin acetate.

Conclusion and Implication

  • The research concluded that long-term treatment with desmopressin acetate could effectively manage central diabetes insipidus in horses without causing any adverse effects.
  • This study provides a significant contribution towards veterinary medicine, establishing a practical and effective approach for long-term treatment of central diabetes insipidus in horses.

Cite This Article

APA
Durie I, van Galen G. (2020). Long-term hormone replacement treatment in a horse with central diabetes insipidus. J Vet Intern Med, 34(2), 1013-1017. https://doi.org/10.1111/jvim.15697

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 34
Issue: 2
Pages: 1013-1017

Researcher Affiliations

Durie, Inge
  • Equine Referral Hospital, Evidensia Specialisthästsjukhuset Strömsholm, Strömsholm, Sweden.
van Galen, Gaby
  • Veterinary Teaching Hospital of Camden, University of Sydney, Sydney, Australia.

MeSH Terms

  • Animals
  • Antidiuretic Agents / administration & dosage
  • Antidiuretic Agents / therapeutic use
  • Deamino Arginine Vasopressin / administration & dosage
  • Deamino Arginine Vasopressin / therapeutic use
  • Diabetes Insipidus, Neurogenic / diagnosis
  • Diabetes Insipidus, Neurogenic / drug therapy
  • Diabetes Insipidus, Neurogenic / veterinary
  • Diagnosis, Differential
  • Horse Diseases / diagnosis
  • Horse Diseases / drug therapy
  • Horses
  • Injections, Subcutaneous / veterinary
  • Male

Conflict of Interest Statement

Authors declare no conflict of interest.

References

This article includes 13 references
  1. Schott HC 2nd. Water homeostasis and diabetes insipidus in horses.. Vet Clin North Am Equine Pract 2011 Apr;27(1):175-95.
    pubmed: 21392661doi: 10.1016/j.cveq.2011.01.002google scholar: lookup
  2. Durham AE. Therapeutics for Equine Endocrine Disorders.. Vet Clin North Am Equine Pract 2017 Apr;33(1):127-139.
    pubmed: 28190613doi: 10.1016/j.cveq.2016.11.003google scholar: lookup
  3. Harb MF, Nelson RW, Feldman EC, Scott-Moncrieff JC, Griffey SM. Central diabetes insipidus in dogs: 20 cases (1986-1995).. J Am Vet Med Assoc 1996 Dec 1;209(11):1884-8.
    pubmed: 8944803
  4. Aroch I, Mazaki-Tovi M, Shemesh O, Sarfaty H, Segev G. Central diabetes insipidus in five cats: clinical presentation, diagnosis and oral desmopressin therapy.. J Feline Med Surg 2005 Dec;7(6):333-9.
    pubmed: 15927500doi: 10.1016/j.jfms.2005.03.008google scholar: lookup
  5. Jane JA Jr, Vance ML, Laws ER. Neurogenic diabetes insipidus.. Pituitary 2006;9(4):327-9.
    pubmed: 17080264doi: 10.1007/s11102-006-0414-7google scholar: lookup
  6. Kranenburg LC, Thelen MH, Westermann CM, de Graaf-Roelfsema E, van der Kolk JH. Use of desmopressin eye drops in the treatment of equine congenital central diabetes insipidus.. Vet Rec 2010 Nov 13;167(20):790-1.
    pubmed: 21262613doi: 10.1136/vr.c5125google scholar: lookup
  7. McKenzie EC. Polyuria and polydipsia in horses.. Vet Clin North Am Equine Pract 2007 Dec;23(3):641-53, vii.
    pubmed: 18061855doi: 10.1016/j.cveq.2007.08.001google scholar: lookup
  8. Shiel RC. Diabetes insipidus. In: Ettinger SJ, Feldman EC, Côté E, eds. Textbook of Veterinary Internal Medicine. 8th ed. St Louis, MO: Elsevier Saunders; 2017:365.
  9. Breukink HJ, Van Wegen P, Schotman AJ. Idiopathic diabetes insipidus in a Welsh pony.. Equine Vet J 1983 Jul;15(3):284-7.
  10. Filar J, Ziolo T, Szalecki J. Diabetes insipidus in the course of encephalitis in the horse. Med Weter 1971;27:205‐207.
  11. Moses ME, Johnson PJ, Messer NT, Wilson A. Antidiuretic response of a horse affected with pituitary pars intermedia dysfunction to desmopressin acetate. Equine Vet E 2013;25:111‐115.
  12. Berl T, Verbalis J. Pathophysiology of water metabolism. In: Brenner BM, ed. The Kidney. Vol 1 7th ed. Philadelphia, PA: WB Saunders; 2004:857‐919.
  13. Nichlos R, Peterson ME. Clinical use of the vasopressin analogue desmopressin for the diagnosis and treatment of diabetes insipidus. In: Bonagura JD, Twedt DC, eds. Kirk's Current Veterinary Therapy XV. 1st ed. St Louis, MO: Elsevier Saunders; 2013:73‐75.

Citations

This article has been cited 2 times.
  1. Elder E, Wong D, Johnson K, Robertson H, Marner M, Dembek K. Assessment of the hypothalamic-pituitary-adrenocortical axis function using a vasopressin stimulation test in neonatal foals. J Vet Intern Med 2023 Sep-Oct;37(5):1881-1888.
    doi: 10.1111/jvim.16808pubmed: 37432047google scholar: lookup
  2. van Galen G, Divers TJ, Savage V, Schott HC 2nd, Siwinska N. ECEIM consensus statement on equine kidney disease. J Vet Intern Med 2024 Jul-Aug;38(4):2008-2025.
    doi: 10.1111/jvim.17101pubmed: 38801172google scholar: lookup